New course of treatment with existing drugs for cervical cancer reduces risk of death by 35%

A course of treatment with existing drugs prior to chemoradiation led to a 35% reduction in the risk of death or return of cancer, in trial results presented by researchers from UCL and UCLH.

Related Keywords

Italy ,India ,Mexico ,United Kingdom ,Brazil ,Megan Craig ,Jonathan Ledermann ,Mary Mccormack ,Iain Foulkes ,Cancer Trials Centre ,European Society For Medical Oncology ,Cancer Institute ,Cancer Research United Kingdom ,Trials Centre ,European Society ,Medical Oncology ,Executive Director ,Cancer ,Cervical Cancer ,Drugs ,Carboplatin ,Chemotherapy ,Ncology ,Paclitaxel ,Research ,